Business Description
Novo Nordisk A/S
NAICS : 325412
SIC : 2836
ISIN : US6701002056
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.12 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | 0.23 | |||||
Interest Coverage | 69.78 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 13.52 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24 | |||||
3-Year EBITDA Growth Rate | 26.3 | |||||
3-Year EPS without NRI Growth Rate | 26 | |||||
3-Year FCF Growth Rate | 34.6 | |||||
3-Year Book Growth Rate | 21.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 18.44 | |||||
Future 3-5Y Total Revenue Growth Rate | 18.85 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.15 | |||||
9-Day RSI | 51.99 | |||||
14-Day RSI | 50.98 | |||||
6-1 Month Momentum % | 32.03 | |||||
12-1 Month Momentum % | 51.06 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.82 | |||||
Quick Ratio | 0.64 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 284.46 | |||||
Days Sales Outstanding | 87.92 | |||||
Days Payable | 181.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.12 | |||||
Dividend Payout Ratio | 0.38 | |||||
3-Year Dividend Growth Rate | 18.1 | |||||
Forward Dividend Yield % | 1.12 | |||||
5-Year Yield-on-Cost % | 1.92 | |||||
3-Year Average Share Buyback Ratio | 1.7 | |||||
Shareholder Yield % | 1.8 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 84.6 | |||||
Operating Margin % | 44.16 | |||||
Net Margin % | 36.03 | |||||
FCF Margin % | 29.95 | |||||
ROE % | 92.29 | |||||
ROA % | 30.18 | |||||
ROIC % | 30.03 | |||||
ROC (Joel Greenblatt) % | 138.16 | |||||
ROCE % | 83.59 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 46.34 | |||||
Forward PE Ratio | 38.05 | |||||
PE Ratio without NRI | 46.34 | |||||
Shiller PE Ratio | 84.9 | |||||
Price-to-Owner-Earnings | 45.08 | |||||
PEG Ratio | 2.65 | |||||
PS Ratio | 16.78 | |||||
PB Ratio | 36.38 | |||||
Price-to-Tangible-Book | 83.76 | |||||
Price-to-Free-Cash-Flow | 55.9 | |||||
Price-to-Operating-Cash-Flow | 35.9 | |||||
EV-to-EBIT | 36.25 | |||||
EV-to-Forward-EBIT | 30.8 | |||||
EV-to-EBITDA | 33.3 | |||||
EV-to-Forward-EBITDA | 28.2 | |||||
EV-to-Revenue | 16.55 | |||||
EV-to-Forward-Revenue | 13.65 | |||||
EV-to-FCF | 55.95 | |||||
Price-to-Projected-FCF | 5.15 | |||||
Price-to-DCF (Earnings Based) | 2.16 | |||||
Price-to-DCF (FCF Based) | 2.66 | |||||
Price-to-Median-PS-Value | 2.05 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.87 | |||||
Price-to-Graham-Number | 13.21 | |||||
Earnings Yield (Greenblatt) % | 2.76 | |||||
FCF Yield % | 1.81 | |||||
Forward Rate of Return (Yacktman) % | 17.46 |